Spring, TX—The Coconut Coalition of the Americas (CCA) has launched an initiative to make it clear that coconuts are not tree nut allergens, according to a press release. CCA will spearhead the effort to request that FDA revise the FALCPA Guidance Document to remove coconut from the list of tree...
Washington, DC--As part of its modernization efforts, the FDA has a new system for accepting and storing electronic submissions for new dietary ingredient notification (NDIN) and structure/function claim notification (SFCN). The new system, called the CFSAN Online Submission Module (COSM), has replaced the the FDA Unified Registration Listing System (FURLS).
Denver, CO--USDA and FDA officials were on hand to share important information with companies selling hemp-CBD in dietary supplements at the two-day American Herbal Products Association (AHPA) Hemp-CBD (cannabidiol) Supplement Congress, which took place in Denver earlier this month. “The overwhelming turnout for the first AHPA Hemp-CBD Supplement Congress demonstrates...
Washington, D.C.--The Food and Drug Administration (FDA) has released a guidance for industry with step-by-step instructions for manufacturers on how to convert the previous units of measure for folate, niacin, vitamin A, vitamin D, and vitamin E to the new units required on the updated Nutrition Facts and Supplement Facts...
Washington, D.C.—Scott Gottlieb, M.D., resident fellow at the American Enterprise Institute and former commissioner of FDA, wrote an op-ed in The Washington Post calling on FDA to act quickly and regulate cannabidiol (CBD). Dr. Gottlieb opened the op-ed by noting that CBD is everywhere, and that the market could surpass...
Wakefield, MA--In response to a warning letter from the FDA stating that Curaleaf Hemp was “illegally selling unapproved products containing cannabidiol (CBD) online with unsubstantiated claims that the products treat cancer, Alzheimer’s disease, opioid withdrawal, pain and pet anxiety, among other conditions or diseases," Curaleaf Holdings announced that it been...
Washington, DC--The Food and Drug Administration (FDA) issued a warning letter to Curaleaf, Inc., based in Wakefield, MA, for "illegally selling unapproved products containing cannabidiol (CBD) online with unsubstantiated claims that the products treat cancer, Alzheimer’s disease, opioid withdrawal, pain and pet anxiety, among other conditions or diseases." In a...
Washington, DC--The Natural Products Association (NPA) has filed comments with the Food and Drug Administration (FDA) regarding its review of “Responsible Innovation in Dietary Supplements.” NPA said these new comments reinforce points made during the Association's presentation at FDA’s May 16 meeting on the same topic. In the comments, NPA...
College Park, MD—On May 16, FDA held a public meeting titled “Responsible Innovation in Dietary Supplements.” The meeting was intended to give interested parties an opportunity to present ideas for maintaining FDA’s ability to protect the public while encouraging responsible innovation within the Industry. A full list of presentations can...
Washington, D.C.—Senator Ron Wyden (D-OR) urged FDA to promptly issue guidance that ensures the regulatory pathway Congress intended for the lawful use of CBD as a food additive and a dietary supplement, according to a statement on Senator Wyden’s website. In a letter to Alex Azar, secretary of the Department...
